The Affairs of Organized Medicine 749 The Way I See It Bilingualism - South African style 751 Association News: CMA board considers legal side of limitations statutes and VD control... Canadian Medical Bonspiel, 1975 755 Consumer Viewpoint: Sick magazines need urgent treatment: why are they still in the waiting room? 760 Health Care Delivery: Acute epiglottitis: a potential kiII.... The family doctor in Canada. Part VI: joining an organized voice 770 Medical Economics: Medical dollars and data: collection, recollection. Part II: medicare benefits statisticians 778 Your Leisure: Wordsworth country: vales and hills and daffodils 779 Forthcoming Meetings 785 Classified Advertising 789 Advertisers' Index Funds CMARSP common stock fund unit value Feb. 28, 1975 $24.34 CMARSP insured annuity fund interest rate* Feb. 28, 1975 8.74% CMARSP short-term deposit account unit value Feb. 28, 1975 $10.00 Alta Vista Fund unit value Feb. 28, 1975 $ 9.53 Lancet Performance Fund Limited share value Feb. 28, 1975 $ 7.87 *Interest rate paid on new money contributions invested on date shown. Rate subject to adjustment. CALL YOUR PROVINCIAL DIVISION OFFICE FOR UP TO DATE INFORMATION. REFER TO THE ARTICLE ON '.FILING YOUR 1974 INCOME TAX RETURN" WHICH APPEARED IN THE FEB. 8. 1975 ISSUE OF CMAJ. IT COULD SAVE YOU TAX DOLLARS! Published twice a month by The Canadian Medical Association, C.M.A. House, 1867 Alta Vista Drive, P.0. Box 8650, Ottawa, Ontario KJG 0G8, Canada. Printed by Harpell's Press Co-Operative, Gardenvale, Quebec HOA 180. Postage paid in cash at third-class (quantity) rate Permit No. 0-4. Return postage guaranteed. All reproduction rights reserved. CMA JOURNAL/MARCH 22, 1975/VOL. 112 669 Miiiiii wmm n Canadian Medical Association Dr. Bette Stephenson, president Dr. R. G. Wilson Dr, J. Douglas Wallace chairman, Board of Directors secretary general CMA Publications Committee Dr. Lou Harnick, chairman Dr. P. B. Heaton Dr. O. P. Gialloreto CMA Publications Mr. C. K. Goodman, business manager Mr. N. Hutton Mr. R. M. Sinnott sales manager production manager CMA Journal Scientific Section Dr. J. R. Anderson, scientific editor Dr. D. A. E. Shephard Ann Bolster associate scientific editor assistant scientific editor Mr. D. A. Geekie, director of CMA Communications and Affairs of editor, Affairs of Organized Medicine Organized Medicine Mr. J. Garner Uli de GrandprS associate editor Quebec reporter Information for Contributors Manuscripts micrographs should be indicated. Col¬ our work can be published only at the All material intended for publication author's expense, and reprints contain¬ should be submitted to the editor at the ing colour are much more expensive editorial office of the Journal, P.O. Box than reprints in black and white. 8650, Ottawa, Ont. K1G 0G8, with a Magnification of photomicrographs covering letter requesting consideration must be given. Graphs and diagrams for publication in the Journal. Accept¬ should be drawn with India ink. Tables ance is subject to the understanding should be numbered in Roman numer¬ that such material is submitted solely als. Each table should be typed on a to the Journal, and will not be re- separate sheet and an explanatory title printed without the consent of both the should be supplied. The author's name editor and author. The editor reserves should appear at the top of the page. the right to make such editorial changes as are considered necessary to ensure References correctness of grammar, clarification of References should be limited to the obscurities or conformity to Journal Articles should be double- minimum necessary, and authors are style. typed responsible for their accuracy. They spaced on paper 8V2" x 11", and the should be checked with the and one should be sub¬ original original copy sources, designated by Arabic numerals mitted. A factual English summary (and in the text, numbered in and a French if of 150 sequence resume, possible) typed double-spaced on a separate words should also be submitted. Five sheet in accordance with the style to eight keywords should be listed on a The Canadian Medical As¬ separate sheet; these are nouns taken adopted by from the under which the author sociation Journal in July 1971. Each article, periodical reference should include »n believes his work should be subject- order: the author's name and initials indexed. Manuscripts may be submitted in the title of the in or French. capital letters, article, English abbreviated jornal name, volume num¬ Illustrations and tabtes ber, page number and year. The abbre- viations of journal names should be lllustrations should be referred to as those defined in the Index Medicus "Figures" and numbered in Arabic nu¬ 1971 (e.g. 2. ROSEN HJ: Lumbar inter- merals. Each should be mounted on a vertebral disc surgery: review of 300 separate sheet and identified by number cases. Can Med Assoc J 101: 317,1969). and name of author. (Please note that References to books should include in photographs are damaged by writing order: author's name and initials in on the back.) A list of explanatory capital letters; title of book or article in legends for all the figures should be book; number of edition; editor(s), when typed on another sheet. Photographs applicable; city of publication; name of should be glossy prints, untrimmed and publishing house, year of publication; preferable not larger than 8" wide and page number, if a specific reference 10" deep. Patients must not be recogn- (e.g. GOODMAN LS, GILMAN A: Phar- izable in photographs unless written macological Basis of Therapeutics, consent has been obtained and sup¬ third ed. New York, Macmillan, 1965, plied with the manuscript. The top of p 925). A more complete list of require¬ photographs, radiographs and photo- ments may be obtained from the editor. Rates The Journal is published twice each month. It is supplied to paid-up members of The Canadian Medical Subscription Association as a perquisite of membership. Medical libraries, hospitals and individuals in Canada may subscribe to the Journal at $24.00 per year, payable in advance. The same rate and condition apply to subscribers in the United States. Subscriptions elsewhere are available at $30.00 per year, payable in advance. There is a special rate for undergraduates in medicine residing in Canada of $7.00 per year. Single copies (current issue) available at $1.50 each. All back issues $2.50 each. Subscriptions and all relative correspondence should be addressed to the Membership department, The Canadian Medical Association, CMA House, Box 8650, Ottawa, Ont. K1G 0G8. Notification of change of address should be forwarded 1 month before the date on which it becomes effective. CMA JOURNAL/MARCH 22, 1975/VOL. 112 673 tions, this will be a slow and difficult 85% 4. SLONE D, HEINONEN OP, MoNsoN RR, et al: of all therapeutic agents are not Maternal drug exposure and fetal abnormali- crusade. We must also keep in mind approved for use in infants, children ties. Clan Pharmacol Ther 14: 648, 1973 5. HERBST AL, ULFELDER H, POSKANZER DC: that with the advent of intrauterine and pregnant women because conclu- Adenocarcinoma of the vagina: association of maternal stilbesterol therapy with tumor diagnosis the need for prescription of sive evidence of their safety and effi- appearance in young women. N Engi I Med drugs to the pregnant woman for the cacy in this population is not available, 284: 878, 1971 6. SHNIDER SM, WAY EL: Plasma levels of treatment of her fetus is already at but many are administered in ignorance lidocaine (Xylocaine®) in mother and new- born following obstetrical conduction anes- hand. We must acquire sufficient data with potential hazard to the patient. thesia. Anesthesiology 29: 951, 1968 from human studies to make fetal ther- Resolution of this vexing problem will 7. Tait.o K, RAJAMAKI A: Foetal and maternal plasma levels of mepivacaine and foetal acid- apeutics as founded upon fact as is be achieved only if fundamental and base balance and heart rate after paracervical block during labour. Br I Anaesth 43: 300, therapeutics in the adult organism. This clinical investigative - activities in the 1971 requires more research into, and a area of obstetric and pediatric pharma- 8. BLavaR WA, BRECKENRIDGE RT: Studies on the detection of adverse reactions in the greater understanding of, the disposi- cology are expanded in many direc- newborn. JAMA 213: 2049, 1970 9. PALMISANO PA, CASSADY G: Salicylate ex- tion of drugs within the maternal- tions. p.osure in the perinate. JAMA 209: 556, 1969 fetal-placental unit and the effects of 10. BECKER RF, LimB CRD, KING JE: Experi- mental studies on nicotine absorption in rats drugs upon the fetus. Furthermore, this References during pregnancy. Am I Obstet Gynecol 100: 957, 1968 information can be gained only from 1. HILL RM: Drugs ingested by pregnant wom- 11. CoLa PV, HAWKINS LH, RosaRTs D: Smok- studies in pregnant women and at this en. Gun Pharmacol Ther 14: 654, 1973 ing during pregnancy and its effects on the 2. FORFAR JO, NELSON MM: Epidemiology of fetus. I Obstet Gynaecol Br Commonw 79: time the social and political climate is drugs taken by pregnant women: drugs that 782, 1972 may effect the fetus adversely. Ibid, p 632 12. EDWARDS CC JR (Commissioner of the FDA): decidedly against fetal research. 3. YERUSHALMY J, MILKOVICH L: Evaluation of Address to the 1972 annual meeting of the the teratogenic effect of meclazine in man. American Academy of Pediatrics, New York, It has been estimated12 that 75. to Am J Obstef Gynecol 93: 553, 1965 NY Ak . ORTHOPEDIC SURGERY. Clinical seminar. West- ACUTE AND CHRONIC POISONING. Downtowner ORIENTATION WORKSHOP. For practice-eligible minster Hospital, London. Apr. 2, 1975. Informa- Hotel. Owen Sound, Ont. Apr. 16, 1975.